Skip to content
Clinical Trials – home

Bladder transitional cell carcinoma stage III Basic Information

Clinical trials for Bladder transitional cell carcinoma stage III

Recruiting trials first

See all 2 trials →
Quick filters

2 clinical trials in this condition

Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:F. Hoffmann-La Roche AG
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Fundacion Cris De Investigacion Para Vencer El Cancer
See all 2 trials →filters applied: condition = Bladder transitional cell carcinoma stage III

In short

Bladder transitional cell carcinoma stage III is an advanced form of cancer where abnormal cells have spread beyond the bladder's muscle layer into surrounding tissues, though not yet to distant parts of the body.

Key points

  • Stage III bladder transitional cell carcinoma has penetrated through the bladder's muscle layer into the surrounding fat and may affect nearby organs, but has not spread to distant body sites
  • This type accounts for about ninety percent of all bladder cancers in the United States, making it by far the most common form
  • Men face four times the risk of developing bladder cancer compared to women, and most people diagnosed are over age sixty-five
  • Smoking cigarettes causes about half of all bladder cancer cases, making quitting smoking the single most important prevention step you can take
  • Blood in the urine is usually the first noticeable symptom, though advanced stage III disease also causes pain, frequent urination, fatigue, and unexplained weight loss
  • The cancer cells are called "transitional" because they can uniquely stretch when the bladder fills with urine and shrink when it empties
  • Exposure to certain workplace chemicals used in dyes, rubber, leather, paint, and textiles increases your risk of developing this cancer
  • People who have had bladder cancer before face higher risk of developing transitional cell cancer in other parts of their urinary system, requiring ongoing monitoring

Understanding Stage III Transitional Cell Carcinoma

Stage III bladder transitional cell carcinoma represents a significant point in cancer progression. At this stage, cancer cells that began in the urothelium, which is the special tissue lining the inside of the bladder, have grown deeper through multiple layers of the bladder wall. These cells are called "transitional" because they have a unique ability to stretch when the bladder fills with urine and then shrink back when it empties.

When doctors diagnose stage III bladder cancer, they have determined that the cancer has penetrated through the muscle layer of the bladder wall and reached the fat layer that surrounds the bladder on the outside. In some cases, the cancer may have also spread to nearby organs. In women, this might include the uterus or vagina. In men, it could involve the prostate gland or seminal vesicles. However, at stage III, the cancer has not yet traveled to distant sites in the body like the lungs or bones.

This stage is also referred to as "locally advanced" bladder cancer because while it has spread beyond its original location, it remains confined to the region around the bladder. Understanding exactly how far the cancer has spread helps doctors create the most appropriate treatment plan for each person.

How Common Is This Cancer?

Transitional cell carcinoma, also known as urothelial carcinoma, is by far the most common type of bladder cancer. It accounts for approximately ninety percent of all bladder cancer cases diagnosed in the United States. This means that nine out of every ten people with bladder cancer have this particular type.

Bladder cancer does not affect everyone equally. Men are significantly more likely to develop this cancer than women. In fact, men face four times the risk of developing bladder cancer compared to women. Age also plays an important role, as most people diagnosed with this cancer are over the age of sixty-five.

While transitional cell carcinoma can occur in the kidneys and ureters, these locations are much less common. Only about seven percent of kidney cancers are transitional cell type. The bladder remains the primary site where this cancer develops.

What Causes This Type of Cancer?

Medical researchers do not know the exact cause of transitional cell carcinoma, but they understand that it starts when healthy urothelial cells change in harmful ways. These changes, called mutations, cause the cells to grow without control and refuse to die when they should. Instead of functioning normally, these mutated cells multiply rapidly and form tumors. Without treatment, these cancer cells can invade deeper tissues and potentially spread to other parts of the body.

The process begins with damage or changes to the genetic material inside urothelial cells. These are the special cells that line the bladder, ureters, and part of the kidney. The genetic changes affect how these cells grow and divide. Rather than following the body's normal controls, the cells begin dividing uncontrollably, creating masses of abnormal tissue.

Risk Factors That Increase Your Chances

Several factors can increase the likelihood of developing transitional cell carcinoma of the bladder. Cigarette smoking stands out as one of the most significant risk factors. Smoking is thought to be responsible for about half of all bladder cancer cases. When you smoke, your bladder works hard to filter out the harmful chemicals from cigarette smoke. Over time, this constant exposure damages the cells lining the bladder, increasing cancer risk.

Your work environment may also put you at higher risk. People who work with certain chemicals face increased danger of developing bladder cancer. These chemicals are commonly found in industries that produce dyes, rubber, leather, paint, and textiles. Hair stylists and barbers may also be exposed to risky chemicals in hairdressing supplies. Regular contact with these substances over many years can damage bladder cells.

A personal history of bladder cancer significantly raises your risk of developing transitional cell cancer in other parts of the urinary system, particularly the renal pelvis and ureters. Since these areas share the same type of cell lining as the bladder, people who have had bladder cancer need to remain vigilant about symptoms and follow-up care.

Recognizing the Symptoms

In the earlier stages of bladder cancer, symptoms may not appear right away. However, as the cancer advances to stage III, symptoms usually become more noticeable and may significantly affect daily life. Blood in the urine, medically called hematuria, is typically the first symptom that people notice. The urine may appear pink, orange, or dark red. Sometimes the blood is not visible to the naked eye but can be detected through laboratory tests.

Stage III bladder cancer often causes a range of urinary problems. You might feel the need to urinate much more frequently than usual, or experience pain and burning when you urinate. Some people find they cannot urinate at all, which requires immediate medical attention. These symptoms occur because the tumor is large enough to interfere with normal bladder function.

As the cancer progresses, systemic symptoms begin to appear. These are signs that affect your whole body rather than just the bladder area. Many people experience persistent lower back pain that does not go away with rest. The pain may feel dull and constant, affecting your ability to move comfortably. You might notice unexplained weight loss even though you have not changed your eating habits or exercise routine. A general feeling of fatigue or tiredness that does not improve with rest is also common.

Some people with stage III bladder cancer develop swelling in their feet or legs. This happens when the tumor presses on blood vessels or lymph vessels, preventing proper fluid drainage. If the cancer affects certain areas, bone pain may develop. Loss of appetite is another symptom that many people experience, which can contribute to weight loss and weakness.

Ways to Reduce Your Risk

While you cannot prevent all cases of bladder cancer, you can take meaningful steps to lower your risk. The single most important action you can take is to quit smoking if you smoke, or never start if you do not. Since smoking causes about half of all bladder cancers, quitting dramatically reduces your risk. If you need help quitting, talk with your doctor about medications or programs that support smoking cessation.

Protecting yourself from harmful chemical exposure is another important prevention strategy. If you work in an industry where you come into contact with chemicals used in dyes, rubber, leather, paint, textiles, or hairdressing products, follow all safety guidelines carefully. Wear protective equipment, ensure proper ventilation, and wash your hands thoroughly after handling these substances. Talk with your employer about safety measures and any concerns you have about chemical exposure.

Drinking plenty of fluids, especially water, may help protect your bladder. Aim to drink six to eight glasses of water each day. Staying well-hydrated helps dilute potentially harmful substances in your urine and encourages frequent urination, which flushes these substances out of your bladder before they can cause damage. This simple habit costs nothing but may provide meaningful protection.

Eating a diet rich in fruits and vegetables may help keep your bladder healthy and reduce your risk of developing various types of cancer, including bladder cancer. Try to eat at least five servings of fruits and vegetables every day. Include whole grains in your meals several times daily. These foods provide nutrients and compounds that support your body's natural defenses against cell damage.

How Cancer Changes Normal Bladder Function

To understand what happens in stage III transitional cell carcinoma, it helps to know how a healthy bladder works. Your bladder is a hollow, balloon-shaped organ located in the lower part of your abdomen. It has a muscular wall that can expand to hold urine and contract to push urine out through a tube called the urethra. The inside of the bladder is lined with layers of specialized cells called urothelial or transitional cells.

These transitional cells have a remarkable ability that gives them their name. When your bladder fills with urine, these cells can stretch and flatten, allowing the bladder to expand like a balloon. When you urinate and empty your bladder, the cells return to their original rounded shape, and the bladder shrinks back down. This flexibility is essential for normal bladder function.

In stage III transitional cell carcinoma, the cancer has grown through several important layers of the bladder wall. The bladder wall consists of multiple layers, starting with the urothelial lining on the inside, followed by a layer of connective tissue, then a thick layer of muscle, and finally a layer of fat on the outside. In stage III cancer, abnormal cells have invaded through the muscle layer and into the fat layer that surrounds the bladder. This represents significant progression from the inner lining where the cancer began.

As the tumor grows through these layers, it disrupts normal bladder function in several ways. The bladder may lose its ability to expand properly, reducing the amount of urine it can hold. This explains why people with advanced bladder cancer often need to urinate very frequently. The tumor can also damage nerves in the bladder wall, leading to pain or the inability to sense when the bladder is full.

When cancer reaches the outer fat layer and potentially spreads to nearby organs, it can affect more than just the bladder. In women, if the cancer spreads to the uterus or vagina, it may cause bleeding or pain during intercourse. In men, spread to the prostate or seminal vesicles can affect urinary and sexual function. The cancer may also press on or invade blood vessels, causing swelling in the legs and feet.

At the cellular level, cancer cells behave very differently from normal urothelial cells. While healthy cells grow, divide, and die in an orderly way controlled by the body, cancer cells ignore these controls. They divide rapidly without stopping, refuse to die when they should, and can invade surrounding tissues. These cells may also develop the ability to break away and travel through blood vessels or lymph vessels to other parts of the body, though in stage III cancer, distant spread has not yet occurred.

Did you know?

  1. The urothelial cells lining your bladder are sometimes called "transitional" cells because they can physically change shape, stretching when your bladder fills and shrinking when it empties—a unique ability among body cells.
  2. Men are four times more likely to develop bladder cancer than women, though researchers still do not fully understand why this dramatic gender difference exists.
  3. Transitional cell carcinoma has a notable tendency to recur even after successful treatment, with up to seventy percent of non-muscle invasive cases returning within two years, requiring lifelong surveillance.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.